CliniPharma

Clinician-based drug discovery and development, basic research on eosinophil chemotaxis and T-cell control of allergic inflammation, development of asthma, allergic rhinitis and sinusitis controller medicine drugs and immunomodulaton, Crohn's disease treatment

Activity:

- Research & Development

Product / Technology type(s) covered:

- Cosmoceuticals
- Curative
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Preventive
- Proteins

Therapeutic targets:

- Allergy
- Asthma
- Gastrointestinal
- Genetics
- Respiratory Medicine

Markets Covered

a. HeadQuarter: United Kingdom

b. Continent(s) active: Europe , North America , Australia/New-Zealand

c. Countries active: UK, Europe, USA, Australis, Hong Kong,

Corporate data:

Number of Employees: 20

Turnover:

Amount:	Year:	Currency:
under development	2006	US Dollar

Year founded: 2003

Stock options:

	Symbol	Exchange
1	NA
	Symbol	Exchange
2	NA
	Symbol	Exchange
3	NA

Partners / Alliances: NA